Emerging structural biology of lipid G protein-coupled receptors

被引:42
作者
Audet, Martin
Stevens, Raymond C.
机构
[1] Univ Southern Calif, Michelson Ctr Convergent Biosci, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA
[2] Univ Southern Calif, Michelson Ctr Convergent Biosci, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA
关键词
crystal structures; G protein-coupled receptor; bioactive lipids; membrane proteins; allosteric ligands; RESOLUTION CRYSTAL-STRUCTURE; BINDING; AUTOTAXIN; INSIGHTS; CANNABINOIDS; ACTIVATION; AGONISTS; PATHWAY; DRUGS; SITES;
D O I
10.1002/pro.3509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The first crystal structure of a G protein-coupled receptor (GPCR) was that of the bovine rhodopsin, solved in 2000, and is a light receptor within retina rode cells that enables vision by transducing a conformational signal from the light-induced isomerization of retinal covalently bound to the receptor. More than 7 years after this initial discovery and following more than 20 years of technological developments in GPCR expression, stabilization, and crystallography, the high-resolution structure of the adrenaline binding beta(2)-adrenergic receptor, a ligand diffusible receptor, was discovered. Since then, high-resolution structures of more than 53 unique GPCRs have been determined leading to a significant improvement in our understanding of the basic mechanisms of ligand-binding and ligand-mediated receptor activation that revolutionized the field of structural molecular pharmacology of GPCRs. Recently, several structures of eight unique lipid-binding receptors, one of the most difficult GPCR families to study, have been reported. This review presents the outstanding structural and pharmacological features that have emerged from these new lipid receptor structures. The impact of these findings goes beyond mechanistic insights, providing evidence of the fundamental role of GPCRs in the physiological integration of the lipid signaling system, and highlighting the importance of sustained research into the structural biology of GPCRs for the development of new therapeutics targeting lipid receptors.
引用
收藏
页码:292 / 304
页数:13
相关论文
共 63 条
[1]   THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors [J].
Alexander, Stephen P. H. ;
Christopoulos, Arthur ;
Davenport, Anthony P. ;
Kelly, Eamonn ;
Marrion, Neil V. ;
Peters, John A. ;
Faccenda, Elena ;
Harding, Simon D. ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
Southan, Christopher ;
Davies, Jamie A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 :S17-S129
[2]   COX-2-derived endocannabinoid metabolites as novel inflammatory mediators [J].
Alhouayek, Mireille ;
Muccioli, Giulio G. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (06) :284-292
[3]   Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor [J].
Audet, Martin ;
White, Kate L. ;
Breton, Billy ;
Zarzycka, Barbara ;
Han, Gye Won ;
Lu, Yan ;
Gati, Cornelius ;
Batyuk, Alexander ;
Popov, Petr ;
Velasquez, Jeffrey ;
Manahan, David ;
Hu, Hao ;
Weierstall, Uwe ;
Liu, Wei ;
Shui, Wenqing ;
Katritch, Vsevolod ;
Cherezov, Vadim ;
Hanson, Michael A. ;
Stevens, Raymond C. .
NATURE CHEMICAL BIOLOGY, 2019, 15 (01) :11-+
[4]   Restructuring G-Protein-Coupled Receptor Activation [J].
Audet, Martin ;
Bouvier, Michel .
CELL, 2012, 151 (01) :14-23
[5]   A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics [J].
Badowski, Melissa E. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) :441-449
[6]   Recent advances in clinical development of leukotriene B4 pathway drugs [J].
Bhatt, L. ;
Roinestad, K. ;
Van, T. ;
Springman, E. B. .
SEMINARS IN IMMUNOLOGY, 2017, 33 (0C) :65-73
[7]   HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation [J].
Blaho, Victoria A. ;
Galvani, Sylvain ;
Engelbrecht, Eric ;
Liu, Catherine ;
Swendeman, Steven L. ;
Kono, Mari ;
Proia, Richard L. ;
Steinman, Lawrence ;
Han, May H. ;
Hla, Timothy .
NATURE, 2015, 523 (7560) :342-+
[8]   A Possible role for Platelet-Activating Factor receptor in Amyotrophic Lateral sclerosis treatment [J].
Briones, Marcelo R. S. ;
Snyder, Amanda M. ;
Ferreira, Renata C. ;
Neely, Elizabeth B. ;
Connor, James R. ;
Broach, James R. .
FRONTIERS IN NEUROLOGY, 2018, 9
[9]   Structural basis for signal recognition and transduction by platelet-activating-factor receptor [J].
Cao, Can ;
Tan, Qiuxiang ;
Xu, Chanjuan ;
He, Lingli ;
Yang, Linlin ;
Zhou, Ye ;
Zhou, Yiwei ;
Qiao, Anna ;
Lu, Minmin ;
Yi, Cuiying ;
Han, Gye Won ;
Wang, Xianping ;
Li, Xuemei ;
Yang, Huaiyu ;
Rao, Zihe ;
Jiang, Hualiang ;
Zhao, Yongfang ;
Liu, Jianfeng ;
Stevens, Raymond C. ;
Zhao, Qiang ;
Zhang, Xuejun C. ;
Wu, Beili .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2018, 25 (06) :488-+
[10]   Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to Gs and Gi [J].
Chen, X. P. ;
Yang, W. ;
Fan, Y. ;
Luo, J. S. ;
Hong, K. ;
Wang, Z. ;
Yan, J. F. ;
Chen, X. ;
Lu, J. X. ;
Benovic, J. L. ;
Zhou, N. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (08) :1817-1834